Xiao, YunTang, JuanGuo, HuiZhao, YixiaTang, RongOuyang, SongZeng, QiumingRappleye, Chad A.Rajaram, Murugesan V. S.Schlesinger, Larry S.Tao, LijianBrown, Gordon D.Langdon, Wallace Y.Li, Belinda T.Zhang, Jian2017-02-022017-02-022016-08Xiao, Y, Tang, J, Guo, H, Zhao, Y, Tang, R, Ouyang, S, Zeng, Q, Rappleye, C A, Rajaram, M V S, Schlesinger, L S, Tao, L, Brown, G D, Langdon, W Y, Li, B T & Zhang, J 2016, 'Targeting CBLB as a potential therapeutic approach for disseminated candidiasis', Nature Medicine, vol. 22, no. 8, pp. 906-914. https://doi.org/10.1038/nm.41411078-8956http://hdl.handle.net/2164/8119We thank J.M. Penninger (University of Toronto) for providing Cblb−/− mice, Y. Iwakura (Tokyo University of Science) for providing Clec4n−/− mice, S. Lipkowitz (National Cancer Institute, US National Institutes of Health) for providing Cblb constructs, X. Lin (MD Anderson Cancer Center) for providing the antibody to mouse dectin-3 and Card9−/− bone marrow cells, P.R. Sundstrom (Dartmouth University) for providing the C. albicans cap1 mutant, and L.D. Chaves (University at Buffalo) for flow cytometric analysis of myeloid cells in the kidneys. We also thank A. Lovett-Racke (Ohio State University) for her advice on in vivo Cblb-knockdown experiments. This work was supported by the US National Institutes of Health (grants R01 AI090901, R01 AI123253, and R21 AI117547; all to J.Z.), the American Heart Association (AHA Great Rivers Associate Grant-in-Aid grant 16GRNT26990004; J.Z.), a start-up fund from the Ohio State University College of Medicine (J.Z.), and the Wellcome Trust (G.D.B.).96365854engR MedicineWellcome TrustRJournal article10.1038/nm.4141228